Morgan Stanley Biom X Inc. Transaction History

Morgan Stanley

  • $1.35 Trillion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 13, 2022
SELL
$12.1 - $20.6 $48,400 - $82,400
-4,000 Closed
0 $0
Q4 2021

Feb 14, 2022
BUY
$14.4 - $30.4 $28,800 - $60,800
2,000 Added 100.0%
4,000 $6,000
Q3 2021

Nov 15, 2021
BUY
$30.6 - $58.1 $61,200 - $116,200
2,000 New
2,000 $6,000

Others Institutions Holding PHGE

# of Institutions
2
Shares Held
301K
Call Options Held
0
Put Options Held
0
View Full List

About BiomX Inc.

PHGE Quotes by TradingView
  • Ticker PHGE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 29,982,300
  • Market Cap $15.3M
  • Description
  • BiomX Inc., a clinical-stage microbiome company, develops products using natural and engineered phage technologies designed to target and kill specific harmful bacteria. It targets bacteria that affect the appearance of skin, as well as chronic diseases, such as inflammatory bowel diseases (IBD), primary sclerosing cholangitis (PSC), cystic fibr...
More about PHGE
Track This Portfolio

Track Morgan Stanley Portfolio

Follow Morgan Stanley and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email